1. Polysaccharide-Based Nanomedicines Targeting Lung Cancer
    Asif Ahmad Bhat et al, 2022, Pharmaceutics CrossRef
  2. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance
    Sajad Fakhri et al, 2023, Cancer and Metastasis Reviews CrossRef
  3. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
    Emiliano Panieri et al, 2021, Antioxidants & Redox Signaling CrossRef
  4. Association of nanoparticles and Nrf2 with various oxidative stress-mediated diseases
    Rekha Thiruvengadam et al, 2023, Chemico-Biological Interactions CrossRef
  5. Unlocking the Potential of Brusatol as an Antitumoral Agent: Molecular Mechanisms and Therapeutic Benefits
    Parameswary V Marar et al, 2023, Revista Brasileira de Farmacognosia CrossRef
  6. A review of Brucea javanica: metabolites, pharmacology and clinical application
    Jing Chen et al, 2024, Frontiers in Pharmacology CrossRef
  7. Effectiveness of Scutellaria baicalensis Georgi root in pregnancy-related diseases: A review
    Dan-na Fang et al, 2023, Journal of Integrative Medicine CrossRef
  8. Targeting Nrf2 may reverse the drug resistance in ovarian cancer
    Danjie Li et al, 2021, Cancer Cell International CrossRef
  9. Identification of chondroitin polymerizing factor (CHPF) as tumor promotor in cholangiocarcinoma through regulating cell proliferation, cell apoptosis and cell migration
    Xiaohui Duan et al, 2021, Cell Cycle CrossRef
  10. Chondroitin Sulphate: An emerging therapeutic multidimensional proteoglycan in colon cancer
    Amina T. Mneimneh et al, 2024, International Journal of Biological Macromolecules CrossRef
  11. Brusatol modulates diverse cancer hallmarks and signaling pathways as a potential cancer therapeutic
    Song-Bin Guo et al, 2022, Acta Materia Medica CrossRef
  12. Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy
    Zerrin Sezgin-Bayindir et al, 2021, Antioxidants CrossRef
  13. Brusatol inhibits the growth of renal cell carcinoma by regulating the PTEN/PI3K/AKT pathway
    Tao Wang et al, 2022, Journal of Ethnopharmacology CrossRef
  14. A critical review: anti-cancer effects of Brucea javanica and the mechanisms
    Haohao Guo et al, 2022, Pharmacological Research - Modern Chinese Medicine CrossRef